NCT03996265 2026-01-15
Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors
University of Rochester
Phase 3 Active not recruiting
Clinical Trials
4 trialsNCT04457180 2022-10-26
A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT01769768 2020-12-19
Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
Novartis
Phase 1 Completed
NCT00079469 2012-03-08
Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke
National Institutes of Health Clinical Center (CC)
Phase NA Completed